Statins reduce pneumonia death rates: Study
April 5th, 2011 - 4:13 pm ICT by ANILondon, Apr 5 (ANI): A study by the London School of Hygiene and Tropical Medicine has suggested that taking statins could help prevent people dying from pneumonia.
The researchers found that the risk of death in the six-month period after diagnosis of pneumonia was substantially lower among those who were already receiving the cholesterol-lowering drugs compared with those who were not.
Previous studies have suggested that statins may be associated with a more favourable outcome after bacterial infection.
This study supports a possible protective effect of statins against mortality in patients with pneumonia.
But the researchers point out that as they looked at patients who were already taking the medication when they developed pneumonia, a randomised clinical trial is needed to determine whether starting a statin at the time of diagnosis has a similar effect
The team of epidemiologists used data from The Health Improvement Network (THIN), a database of computerised medical records of doctors’ practices in the UK, to identify statin users for the study.
They matched each statin user, who were aged over 40 at first prescription of a statin between 1995 and 2006, with up to five non-statin users.
Patients with a record of pneumonia were followed for six months to see if they died and the scientists found that 13 percent (109 out of 847) of statin users died compared with 20 percent (578 out of 2927) of non-statin users.
While the study tried to minimise confounding variables, the researchers point out that they cannot rule out the possibility that unknown differences between statin users and non-users could have contributed to the results.
Lead author Dr Ian Douglas, lecturer in epidemiology at LSHTM, said: “Statins are safe, cheap, and an easy intervention in terms of delivery.
“Given the potential low number needed to treat to prevent a death suggested by this study, we believe that a strong case exists for randomised trials of statins in people with serious infection to determine if a simple and practical intervention at the point of diagnosis of pneumonia has a beneficial effect.”
The study has been published online in the BMJ. (ANI)
- Cholesterol-lowering statins 'kill bacteria' - Nov 18, 2010
- Cholesterol-lowering drugs may improve blood flow after stroke - Apr 27, 2011
- Statin may help fight HIV - Feb 17, 2011
- Statins stave off depression in heart patients - Feb 26, 2012
- Statins 'may prevent re-growth of prostate cancer' - Jun 28, 2010
- Statin use may cut risk of colorectal cancer - Oct 19, 2010
- Cholesterol-lowering drug could protect kidneys after surgery - Apr 12, 2011
- Chronic statin therapy linked to reduced postoperative mortality - Dec 26, 2010
- Statins could help stave off seizures - Oct 26, 2010
- Statins could help prevent prostate cancer, other related diseases - Apr 27, 2009
- Even bosses snub the doctor's orders - Mar 03, 2010
- Vitamin A supplementation 'does not reduce maternal mortality' - May 05, 2010
- Statins may help prevent blood clots in heart patients - Nov 04, 2009
- A jab could lower cholesterol by two-thirds - Nov 15, 2011
- Antibiotic can prevent blinding even with half dosage - Dec 29, 2011
Tags: bacterial infection, cholesterol lowering drugs, clinical trial, confounding variables, death rates, diagnosis of pneumonia, dr ian, epidemiology, favourable outcome, health improvement, improvement network, lecturer, london school of hygiene, london school of hygiene and tropical medicine, medical records, mortality, pneumonia, randomised trials, statin, terms of delivery